Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How do the results of the MADIT II trial impact current sudden cardiac death (SCD) prevention practices?

0
10 Posted

How do the results of the MADIT II trial impact current sudden cardiac death (SCD) prevention practices?

0
10

The results of MADIT II definitively demonstrate that initializing post-myocardial infarction (MI) patients for prophylactic ICD therapy, based on an EF <30%, can significantly reduce their risk of death.1

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.